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Abstract
A subset of children and adults with Wolff-Parkinson-White (WPW) syndrome develop dilated 
cardiomyopathy (DCM). Although DCM may occur in symptomatic WPW patients with 
sustained   tachyarrhythmias,   emerging   evidence   suggests   that   significant   left   ventricular 
dysfunction may arise in WPW in the absence of incessant tachyarrhythmias. An invariable 
electrophysiological feature in this non-tachyarrhythmia type of DCM is the presence of a right-
sided septal or paraseptal accessory pathway. It is thought that premature ventricular activation 
over these accessory pathways  induces septal wall motion abnormalities  and ventricular 
dyssynchrony. LV dyssynchrony induces cellular and structural ventricular remodelling, which 
may have detrimental effects on cardiac performance. This review summarizes recent evidence 
for development of DCM in asymptomatic patients with WPW, discusses its pathogenesis, 
clinical presentation, management and treatment. The prognosis of accessory pathway-induced 
DCM is excellent. LV dysfunction reverses following catheter ablation of the accessory 
pathway, suggesting an association between DCM and ventricular preexcitation. Accessory 
pathway-induced DCM should be suspected in all patients presenting with heart failure and overt 
ventricular preexcitation, in whom no cause for their DCM can be found. 
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Introduction
Clinically relevant arrhythmias are frequently encountered in patients with Wolff-Parkinson-
White (WPW) syndrome [1]. Reentrant supraventricular tachyarrhythmia, with orthodromic 
electrophysiological properties, is the most common arrhythmia in these patients [2]. A less 
common clinical manifestation in WPW is dilated cardiomyopathy (DCM). It has been 
recognized that recurrent and sustained tachyarrhythmia may induce dilated cardiomyopathy 
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(tachyarrhythmia-induced   cardiomyopathy)   [3,4].   However,   our   group   [5,6],   and   other 
investigators [7-12], have recently described another mechanism by which left ventricular (LV) 
dysfunction and DCM may occur in children and adults with overt ventricular preexcitation. 
Two invariable clinical features associated with this type of DCM are: 1) absence of recurrent 
and   sustained   tachyarrhythmias   ("asymptomatic"   WPW),   and   2)   presence   of   right-sided 
accessory pathways, with overt ventricular preexcitation on 12-lead surface electrocardiogram 
(ECG) [5-12]. It is hypothesized that premature ventricular activation over this type of accessory 
pathway induces abnormal ventricular septal movement, LV dyssynchrony, LV remodelling and 
subsequently DCM [7-9]. This review summarizes the clinical and electrophysiologic evidence 
for this association, describes the electrophysiological properties of the accessory pathways, and 
discusses the management, treatment and clinical outcome of patients with "asymptomatic" 
WPW who develop LV dysfunction or DCM.                                                                               
Prevalence of DCM and LV dysfunction in WPW                                                               
The exact prevalence of DCM and LV dysfunction in patients with asymptomatic WPW is 
unknown. Only 27 cases of accessory pathway-induced DCM have been reported thus far [7-11]. 
The clinical and electrophysiological characteristics of these patients are summarized in Table 1. 
In our institution, we have seen 10 children with DCM and asymptomatic WPW during the last 
10 years. However, it seems likely that this incidence has been underestimated. Approximately 
27% of patients with WPW have a right-sided septally located accessory pathway [10], 
suggesting that some patients might have undergone an electrophysiological study (EPS) and 
catheter ablation before DCM developed. It is also possible that many patients have been 
incorrectly diagnosed to have idiopathic DCM.
LV dysfunction has been described in more than 50% of patients with right-sided septal 
accessory pathways [7,9]. Although prospective studies are lacking, small case series show that 
LV dysfunction in these patients may progress over time [7-11]. It is hypothesized that newer 
echocardiographic techniques for regional and global myocardial function quantification, such as 
tissue Doppler imaging or Speckle Tracking echocardiography [13], may demonstrate a much 
higher incidence of (subclinical) LV dysfunction in asymptomatic patients with right-sided 
septal   accessory   pathways.                                                                        
Pathophysiology
At present, the pathogenic mechanism for the development of LV dysfunction and DCM in 
patients with asymptomatic WPW has not yet been fully elucidated. Interestingly, a right-sided 
septal or paraseptal accessory pathway has been documented in all patients with overt ventricular 
preexcitation   who   developed   LV   dysfunction   or   DCM   in   the   absence   of   recurrent 
tachyarrhythmias [5-12]. This finding suggests that the location of the accessory pathway is an 
important feature in the pathogenesis of this disorder. 
Abnormal septal and ventricular wall motion in WPW                                                     
WPW is a disorder of normal cardiac conduction. It is characterized electrocardiographically by 
presystolic depolarization and contraction of a part of the ventricular myocardium via an 
accessory pathway. The effects of premature ventricular activation on cardiac wall motion and 
global ventricular function has intrigued cardiologists [14-17]. Attempts have been made to 
study premature ventricular contraction patterns and wall motion using a variety of non-invasive 
modalities [14-17]. These studies have made several important observations with regard to 
normal   and   abnormal   ventricular   wall   motion   in   WPW   syndrome   [14-20].  
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Table 1. Summary of clinical and electrophysiological characteristics of all patients with Wolff-
Parkinson-White and dilated cardiomyopathy or left ventricular dysfunction reported in the 
literature between 1998 and 2010.
DCM = dilated cardiomyopathy; EF = ejection fraction; FV = fasciculoventricular fiber; LV = left ventricular; n.r. = 
not reported; RF = radiofrequency; SF = shortening fraction; SPWMD = septal-to-posterior wall motion delay; STI 
= speckle tracking imaging;  TDI = tissue Doppler imaging;  VP = ventricular preexcitation; yrs  = years.
*    Accessory pathways are described using the nomenclature presented by the Cardiac Nomenclature Study Group. 
In brief, the proposed terminology is based on anatomic positions, rather than depicting the position of the 
atrioventricular (AV) junctions [29]. Using this terminology, an anteroseptal or parahisian accessory pathway is 
referred to as superoparaseptal; an posteroseptal pathway as inferoparaseptal; and a midseptal accessory pathway as 
septal.  
**    DCM was defined as a LV end-diastolic dimension above the > 97th percentile of heart size corrected for 
weight with a shortening fraction of < 25% or ejection fraction < 45% [5]. Patients who did not meet these criteria 
are   grouped   as   LV   dysfunction.                                                                            
Left-sided accessory pathways may produce a typical premature anterior motion of the LV 
posterior wall, which can be identified on M-mode echocardiography as a small, distinct bump in 
early systole of the LV posterior wall [14]. On the other hand, right-sided accessory pathways 
may   induce   septal   wall   motion   abnormalities,   with   similarities   to   those   septal   motion 
abnormalities seen in patients with left bundle branch block (LBBB) [21]. The abnormal septal 
motion pattern in patients with right-sided preexcitation consists of an early systolic posterior 
movement, a subsequent midsystolic anterior movement, with a delay in the usual late systolic 
septal movement. In the majority of these patients, the second posterior septal movement is 
interrupted by a prominent septal notch [15]. Although LV function was not measured in the 
earlier studies, it was found that the degree of abnormal ventricular contraction was dependent 
on the location of the accessory pathway in the heart [14-17].                                  
Right sided accessory pathways and LV function                                                                         
Recently, several investigators have demonstrated reduced systolic LV function in patients with 
right- sided septal and paraseptal accessory pathways [7,9]. A lower LV ejection fraction was 
noted in 56% of patients with septal and paraseptal accessory pathways [9]. In a study by Know 
et al. [7], systolic function was reduced in all patients with septal pathways, compared to patients 
with left or right-sided free wall pathways.                                                   
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An important clinical finding is that cardiac function improves and normalizes in patients with 
LV dysfunction or DCM, following loss of ventricular preexcitation, either spontaneously or due 
to cardiac catheter ablation or medical therapy [5-12]. Moreover, several reports have shown an 
acute increase in LV systolic function directly following catheter ablation of the septal accessory 
pathway [5-7,9]. LV reverse remodelling and complete recovery of cardiac function occurs in 
the first weeks after loss of ventricular preexcitation [5-7,9], further supporting the pathogenic 
concept of accessory pathway-induced LV dysfunction and DCM.                              
Detrimental effects of ventricular dyssynchrony on cardiac function                                   
Septal accessory pathway-induced ventricular dyssynchrony is an important feature in the 
development of LV dysfunction and DCM [5,7,9]. We observed that the degree of dyssynchrony 
increased during follow-up in patients with asymptomatic WPW who subsequently developed 
DCM [5]. This pathogenetic concept is further supported by recent clinical and experimental 
work, demonstrating the detrimental effects of LV dyssynchrony on cardiac performance [22-
25].    
As timing is crucial for synchronous ventricular contraction and regional myocardial function, a 
delay in electrical activation of a myocardial segment, due to left bundle branch block (LBBB), 
right ventricular apical pacing, or chronic heart failure, may contribute to cardiac pump 
inefficiency [22-25]. Using tagged-MRI, Prinzen et al. [23] demonstrated in a canine model of 
LV dyssynchrony that systolic strain and wall stress, as well as external work are reduced in 
early-activated myocardial regions and increased in late-activated regions. This study explained 
why the energy generated by myocardial regions which are shorthening is absorbed by stretched 
regions, rather than resulting in propogation of blood or pressure generation. This change in 
strain and wall stress may result in wall motion abnormalities, myocardial perfusion defects, 
changes in coronary blood flow and regional molecular abnormalities, increased LV cavity 
volume, and asymmetrical changes in LV wall thickness, leading to reduced systolic cardiac 
function and heart failure [22-25].                                                                             
Two recent studies used conventional echocardiographic and speckle tracking imaging methods 
to quantify LV dyssynchrony in patients with WPW and septal accessory pathways [7,9]. Pre-
ablation, most patients with septal accessory pathways showed significant LV dyssynchrony. 
Not   surprisingly,   LV   dyssynchrony   disappeared   following   catheter   ablation   (electrical 
resynchronization) with subsequent increase in systolic cardiac function [7,9]. It was further 
hypothesized that early septal activation induces dyskinetic/dyssynchronous septal motion, 
analogous to right ventricular apical pacing-induced LBBB [5,6,9,21]. This dyssynchronous 
septal myocardial segment may function much like an aneurysm. This so-called aneurysm may 
induce adverse LV remodelling with progressive dilation, with DCM as the most severe 
complication of septal accessory pathway-induced dyssynchrony [5-10]. These clinical studies 
further support the importance of dyssynchrony in the pathogenesis of LV dysfunction in 
patients with ventricular preexcitation.                                                                                           
However, not all patients with ventricular preexcitation and right-sided accessory pathways seem 
to be at risk for developing severe LV dysfunction or DCM. Possibly, the degree of pathway-
induced LV dyssynchrony is an additional risk factor in these patients. Recent work suggests that 
different types of septal accessory pathways may induce a variable degree of LV dyssynchrony 
[5-7,9]. Interestingly,  LV dysfunction was more pronounced in patients  with septal and 
superoparaseptal pathways compared to patients with an inferoparaseptal pathway, probably due 
to a higher degree of pathway-mediated LV dyssynchrony [9]. However, this hypothesis 
warrants further prospective clinical studies.                                                             
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Clinical management and treatment                                                                                       
Patients with WPW and DCM                                                                                         
As with all forms of heart failure and DCM in pediatric and adult patients, the underlying 
diagnosis must be considered. All patients should undergo standard electrocardiographic and 
echocardiographic   assessment.   Although   there   are   certain   age-related   differences   in   the 
diagnostic work-up, the approach has to be individualized, depending on clinical findings, age 
and family history. A comprehensive summary of various important aspects in the diagnostic 
work-up of patients presenting with DCM have been well reviewed elsewhere [26,27]. In 
general, septal accessory pathway-induced DCM should be suspected in all patients presenting 
with DCM and overt ventricular preexcitation. This diagnosis is considered when other causes of 
DCM are excluded, particularly tachyarrhythmia-mediated DCM.                                    
The prognosis of right-sided accessory pathway-induced DCM is excellent, when the diagnosis 
is suspected early in the clinical course and appropriate therapy is initiated [5-12]. The primary 
therapy for patients with asymptomatic WPW and accessory pathway-induced DCM is catheter 
ablation of the accessory pathway [1,2]. Cardiac catheter ablation has been proven an effective 
and safe therapy for patients with WPW-syndrome [1,2]. This approach is supported by the rapid 
normalization of cardiac function after loss of ventricular preexcitation.                        
Although catheter ablation is now considered as the standard therapy in adults and children > 12 
kg   with   tachyarrhythmias   [1,2,28],   it   may   be   associated   with   an   unacceptable   risk   of 
complications in infants and small children. Due to these safety concerns, an alternative therapy 
may be offered in this pediatric age-group. Cadrin-Tourigny et al. described two small infants 
with septal accessory pathway-induced DCM who were successfully treated with amiodarone 
[10]. In both patients, pharmacological suppression of ventricular preexcitation was achieved 
within 3 months after amiodarone was started. LV function improved in both cases.          
Patients with WPW and LV dysfunction                                                                             
Many asymptomatic patients with WPW and septal accessory pathways have LV dysfunction 
[7,9]. The extent of LV dysfunction can nowadays be accurately quantified using tissue Doppler 
imaging or 2D speckle tracking echocardiography [13]. In our institution, we use 2D speckle 
tracking imaging to quantify global and regional myocardial function, and degree of ventricular 
dyssynchrony. Figures 1 and 2 show an example of this approach in a child with asymptomatic 
WPW and LV dysfunction. Although the therapy of choice in these patients is not yet known, 
close echocardiographic monitoring of cardiac size and function is mandatory. It seems 
reasonable that catheter ablation should be reserved for those patients in whom progression of 
adverse LV remodelling, dyssynchrony and deteriorating cardiac function are demonstrated 
during follow-up. 
Another interesting aspect in the clinical management of patients with WPW and LV dysfunction 
is whether QRS duration can be used for assessment of degree of ventricular dyssynchrony. 
Recent reports have shown an increased QRS duration in patients with septal and paraseptal 
accessory pathways [7,9]. However, this observation was not confirmed in our studies [5,6]. 
Therefore, QRS duration alone cannot identify all patients at risk for DCM. This may be 
particularly true for children, in whom intracardiac conduction velocities may be more rapid. 
Other non-invasive methods should be included in the risk stratification of these patients. 
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Figure 1. Radial strain assessment using 2D speckle tracking echocardiography. Radial two-dimensional strain in 
the parasternal short-axis view at the mid-ventricular level of a child with a septal accessory pathway and LV 
dysfunction. There is an inhomogeneous pattern of radial strain, with severely reduced peak radial strain values for 
septal myocardial segments (yellow and red arrows). Radial peak strain values are presented as positive values.
Figure 2. Longitudinal peak systolic strain values and curves of 6 myocardial segments obtained from a 4-chamber 
view in the same patient as in Figure 1. The septal basal segment (yellow arrow) shows reduced longitudinal peak 
systolic strain compared to the other segments. The septal basal segment stretches and relaxes in early systole, 
demonstrating regional systolic dysfunction. In addition, maximal peak systolic strain occurs after closure of the 
aortic valve (AVC). This part of the ventricle may function as an aneurysm during follow-up, inducing adverse 
remodelling and dyssynchrony (see text for further explanation).                                                                             
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 10 (6): 248-256 (2010)Udink ten Cate FEA et al, “Dyssynchrony in WPW syndrome and risk of DCM”                  254
Conclusions
Accessory pathway-induced DCM is a newly recognized form of LV dysfunction in asymptomatic 
WPW patients with right-sided pathways, in the absence of incessant tachyarrhythmias. Right-
sided accessory pathways mediate ventricular dyssynchrony, inducing adverse remodelling and 
DCM. With loss of ventricular preexcitation, either spontaneously or after catheter ablation, LV 
function reverses completely. The prognosis of accessory pathway-induced DCM is excellent. 
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